Patent Assignment
Reel/Frame 012420/0451
Assignment of Assignor's Interest
Recorded: 2001-12-31
Pages: 4
Assignee
PRO-PHARMACEUTICALS, INC.
189 WELLS AVENUE, NEWTON, MASSACHUSETTS, 02459
Covered Property
(1)
Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019365/0568 →
Change of Name
Jun 4, 2007
From: SAFESCIENCE, INC.
To: GLYCOGENESYS, INC.
Reel/Frame 019365/0596 →
Change of Name
Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Court Appointment of Trustee
Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Assignment of Claims
Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Security Agreement
Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Change of Name
Oct 18, 2012
From: PRO-PHARMACEUTICALS, INC.
To: GALECTIN THERAPEUTICS INC.
Reel/Frame 029150/0654 →
Release of Security Interest
Sep 17, 2019
From: 10X FUND L.P.
To: GALECTIN THERAPEUTICS, INC.
Reel/Frame 050399/0679 →